Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check5 days agoChange DetectedA site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page remains a 403 error screen.SummaryDifference0.2%

- Check19 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study details and navigation with an access-denied notice. This indicates restricted access rather than an update to the study data.SummaryDifference17%

- Check61 days agoChange DetectedFooter revision text updated from v3.6.5 to v3.6.6, signaling a recent site update.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now displays revision v3.6.5, replacing v3.6.4, indicating an update to the page's underlying template or build. This is an internal version update and does not alter the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.